Head-to-head · free
DexCom, Inc. vs GE HealthCare
DXCM vs GEHC — return on capital, cash generation, margins and balance sheet side by side.
DXCM
6 / 8
measures where DXCM leads
GEHC
2 / 8
measures where GEHC leads
A simple count of which company scores better on each measure — not a recommendation to buy or sell.
| Measure | DXCM · FY2025 | GEHC · FY2025 |
|---|---|---|
| Revenue | $4.7B | $20.6B |
| Net income | $836.3M | $2.1B |
| Revenue growth (yearly, multi-year) | 17.5% | 2.7% |
| Free cash flow | $1.1B | — |
| Free cash flow margin | 23.1% | — |
| Net cash / (debt) | — | — |
| ROIC | 15.8% | 10.8% |
| Return on equity | 34.5% | 22.1% |
| Gross margin | 60.1% | 40.0% |
| Operating margin | 19.6% | 13.4% |
| Net debt / EBITDA | 0.28x | 1.65x |
Figures are as reported by each company; latest fiscal year shown.
Where DexCom, Inc.'s cash went (FY2025)
- Capital spending
- $363.5M
- Buybacks
- —
- Dividends
- —
- Acquisitions
- —
- Net debt issued / (repaid)
- —
Where GE HealthCare's cash went (FY2025)
- Capital spending
- —
- Buybacks
- —
- Dividends
- —
- Acquisitions
- —
- Net debt issued / (repaid)
- —
Ask which business is stronger
"Which one reinvests at higher returns?" "Who carries more risk in its filings?" Get answers drawn straight from both companies' filings.
Compare them free